Daniel W. Muehl
2019 - Clovis Oncology
Compensation breakdown
| Bonus | $216,359 |
|---|---|
| Option Awards | $571,182 |
| Salary | $453,683 |
| Stock Awards | $2,317,037 |
| Other | $21,410 |
| Total | $3,579,671 |
Muehl received $2.3M in stock awards, accounting for 65% of the total pay in 2019.
Muehl also received $216.4K in bonus, $571.2K in option awards, $453.7K in salary and $21.4K in other compensation.
Rankings
In 2019, Daniel W. Muehl's compensation ranked 3,389th out of 13,971 executives tracked by ExecPay. In other words, Muehl earned more than 75.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,389 out of 13,971 | 76th |
Division Manufacturing | 1,230 out of 5,692 | 78th |
Major group Chemicals And Allied Products | 419 out of 2,189 | 81st |
Industry group Drugs | 347 out of 1,875 | 82nd |
Industry Pharmaceutical Preparations | 260 out of 1,387 | 81st |
Pay ratio
| Daniel W. Muehl's Pay | $3,579,671 |
|---|---|
| Median Employee's Pay | $262,806 |
| Pay Ratio | 14to 1 |
In 2019, the annual total compensation of Daniel W. Muehl was $3,579,671.
The annual total compensation of the median employee at Clovis Oncology was $262,806.
The ratio of Daniel W. Muehl's pay to the pay of median employee was therefore 14 to one.
Muehl's colleagues
We found four more compensation records of executives who worked with Daniel W. Muehl at Clovis Oncology in 2019.
News
April 27, 2022
April 28, 2021
April 24, 2020
April 26, 2019